INHIBITION OF THE GROWTH OF A HUMAN NASOPHARYNGEAL CARCINOMA CELL-LINE BY BFGF IS MEDIATED VIA FGFR-1

被引:5
|
作者
CHEN, JK [1 ]
CHAO, HH [1 ]
YANG, VC [1 ]
机构
[1] TUNGHAI UNIV, INST BIOL GRAD, TAICHUNG 40704, TAIWAN
关键词
FIBROBLAST GROWTH FACTORS; CARCINOMA CELLS; GROWTH INHIBITION; FGF RECEPTOR SUBTYPES; HEPARIN-LIKE MOLECULES;
D O I
10.1096/fasebj.9.12.7672514
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growth of CG-1 human nasopharyngeal carcinoma cell line and five of its randomly selected, single cell-derived subline cells is inhibited by bFGF in an autocrine and paracrine manner. In contrast, aFGF, which has a 55% homology in amino acid sequence with bFGF, stimulates cell growth. Basic FGF binds to specific cell surface high-affinity receptor sites with an apparent K-d of 105 pM. Of the two lines examined, the high-affinity binding sites for bFGF are calculated to be 1200 and 2600 per cell. The biological effect of bFGF is conveyed through its binding to the high-affinity receptor sites and the binding is dependent on the presence of cell surface heparin-like molecules, as treatment of cells with heparitinase or sodium chlorate abolishes high-affinity binding and growth inhibition. In contrast, similar treatment has no obvious effect on the growth-stimulatory effect of aFGF. Experimental results are also presented showing that the growth inhibition by bFGF is mediated through type I FGF receptors. These results suggest that bFGF and aFGF act via distinct receptor types to oppositely regulate the growth of CG-1 and subline cells.
引用
收藏
页码:1211 / 1219
页数:9
相关论文
共 50 条
  • [21] Synergistic inhibitory effect of cetuximab and tectochrysin on human colon cancer cell growth via inhibition of EGFR signal
    Park, Mi Hee
    Hong, Ji Eun
    Hwang, Chul Ju
    Choi, Mingi
    Choi, Jeong Soon
    An, Young Jin
    Son, Dong Ju
    Hong, Jin Tae
    ARCHIVES OF PHARMACAL RESEARCH, 2016, 39 (05) : 721 - 729
  • [22] Inhibition of cell proliferation by 17β-estradiol and heregulin β1 in estrogen receptor negative human breast carcinoma cell lines
    Joo-Yeon Yoo
    Tracy Lessor
    Anne W. Hamburger
    Breast Cancer Research and Treatment, 1998, 51 : 71 - 81
  • [23] MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MEDIATED GROWTH-INHIBITION IN A HEMATOPOIETIC STEM-CELL LINE IS ASSOCIATED WITH INOSITOL 1,4,5-TRISPHOSPHATE GENERATION
    HEYWORTH, CM
    PEARSON, MA
    DEXTER, TM
    WARK, G
    OWENLYNCH, PJ
    WHETTON, AD
    GROWTH FACTORS, 1995, 12 (03) : 165 - 172
  • [24] Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha
    Engers, R
    vanRoy, F
    Heymer, T
    Ramp, U
    Moll, R
    Dienst, M
    Friebe, U
    Pohl, A
    Gabbert, HE
    Gerharz, CD
    BRITISH JOURNAL OF CANCER, 1996, 73 (04) : 491 - 498
  • [25] Growth-inhibitory effects of MOB2 on human hepatic carcinoma cell line SMMC-7721
    Leng, Jian-Jun
    Tan, Hua-Min
    Chen, Ke
    Shen, Wei-Gan
    Tan, Jing-Wang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (48) : 7285 - 7289
  • [26] Dehydroepiandrosterone triggers autophagic cell death in human hepatoma cell line HepG2 via JNK-mediated p62/SQSTM1 expression
    Vegliante, Rolando
    Desideri, Enrico
    Di Leo, Luca
    Ciriolo, Maria Rosa
    CARCINOGENESIS, 2016, 37 (03) : 233 - 244
  • [27] Growth-inhibitory effects of MOB2 on human hepatic carcinoma cell line SMMC-7721
    Jian-Jun Leng
    Hua-Min Tan
    Ke Chen
    Wei-Gan Shen
    Jing-Wang Tan
    World Journal of Gastroenterology, 2012, (48) : 7285 - 7289
  • [28] Growth inhibition by overexpression of human DEAD box protein rck/p54 in cells of a guinea pig cell line
    Akao, Y
    Mizoguchi, H
    Ohishi, N
    Yagi, K
    FEBS LETTERS, 1998, 429 (03): : 279 - 283
  • [29] STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
    Spiotto, MT
    Chung, TDK
    PROSTATE, 2000, 42 (02) : 88 - 98
  • [30] Growth inhibitory effects of somatostatin on human leukemia cell lines mediated by somatostatin receptor subtype 1
    Ishihara, S
    Hassan, S
    Kinoshita, Y
    Moriyama, N
    Fukuda, R
    Maekawa, T
    Okada, A
    Chiba, T
    PEPTIDES, 1999, 20 (03) : 313 - 318